Biofabri

Biofabri

Pharmaceutical-Manufacturing

PORRIÑO, Pontevedra
Spain
Company Tagline

BIOFABRI is a biotech company focused on vaccines for Human health

Industry Category
Pharmaceutical-Manufacturing
Company Description

Biofabri is a leading Spanish biopharmaceutical company specializing in the research, development, and industrial production of human vaccines, complemented by contract manufacturing and distribution services (CDMO) of pharmaceutical products. With a rich heritage of over 70 years in the pharmaceutical industry, Biofabri operates from its primary address at La Relva s/n, 1, PORRIÑO, Pontevedra 36400, ES. Biofabri is dedicated to advancing global health through innovative biotech projects.

Biofabri's most notable project is a vaccine against Tuberculosis, currently in phase Ib, developed in collaboration with the University of Zaragoza, Pasteur Institute, and TB Vaccine Initiative. The company leverages valuable infrastructure and expertise to manage projects from the laboratory stage to large-scale production, ensuring quality and efficacy.

As part of the Zendal group, a biopharmaceutical group focused on vaccines and biotechnology, Biofabri is committed to creating a healthier world. Biofabri continuously seeks opportunities for growth and collaboration within the biopharmaceutical sector. We invite the manager of Biofabri to create a customized and exclusive company showcase and product listing on our platform to further enhance its market presence and commercial development.

Biofabri es una empresa biofarmacéutica española líder especializada en la investigación, el desarrollo y la producción industrial de vacunas humanas, complementada con servicios de fabricación y distribución por contrato (CDMO) de productos farmacéuticos. Con una rica herencia de más de 70 años en la industria farmacéutica, Biofabri opera desde su domicilio principal en La Relva s/n, 1, PORRIÑO, Pontevedra 36400, ES. Biofabri se dedica a promover la salud mundial a través de proyectos biotecnológicos innovadores.

El proyecto más notable de Biofabri es una vacuna contra la tuberculosis, actualmente en la fase Ib, desarrollada en colaboración con la Universidad de Zaragoza, el Instituto Pasteur y la Iniciativa de Vacunas contra la TB. La empresa aprovecha una valiosa infraestructura y experiencia para gestionar proyectos desde la fase de laboratorio hasta la producción a gran escala, garantizando la calidad y la eficacia.

Como parte del grupo Zendal, un grupo biofarmacéutico centrado en vacunas y biotecnología, Biofabri se compromete a crear un mundo más saludable. Biofabri busca continuamente oportunidades de crecimiento y colaboración dentro del sector biofarmacéutico. Invitamos al gerente de Biofabri a crear una presentación de empresa y una lista de productos personalizadas y exclusivas en nuestra plataforma para mejorar aún más su presencia en el mercado y su desarrollo comercial.

Key Personnel / Employees
Sara Barja Fernández (Clinical Manager at Biofabri) Ingrid Murillo Jelsbak (Directora de Investigación Clínica. Biofabri) Ana A. Huerta Hernández (Regulatory Affairs at CZ Veterinaria S.A. and Biofabri S.L.) Jelle Thole

Similar Companies

Other organizations in the same industry

Axelerist Inc
Pharmaceutical-Manufacturing

Simplifying Complex Clinical Trial Equipment Supply and Rental Requirements in over 55 Countries.

Armonk, New York
Hypertrust
Pharmaceutical-Manufacturing

Taking Advanced Therapy Medicinal Products (ATMPs) to The Next Level.

Munich, Bavaria
Germany
Pj Pharma
Pharmaceutical-Manufacturing

Progettiamo il tuo Benessere

Brescia, Brescia
Italy
NeoCare
Pharmaceutical-Manufacturing

Alternative Company Names

This company is also known as

Biofabri 生物制造 बायोफॅब्री بيوفابري Биофабри